The contribution of research to Australian policy responses to heroin dependence 1990-2001: A personal retrospection

Addiction

Volumn 99, Issue 5, 2004, Pages 560-569

  Hall, Wayne ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; METHADONE;

AUSTRALIA; CAUSE OF DEATH; CLINICAL RESEARCH; CRIME; DRUG OVERDOSE; FINANCIAL MANAGEMENT; HEALTH CARE POLICY; HEALTH SERVICE; HEROIN DEPENDENCE; HUMAN; HUMAN RIGHTS; MAINTENANCE THERAPY; MANAGEMENT; MORTALITY; PRESCRIPTION; PUBLIC HEALTH; REVIEW;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

AUSTRALIA; BIOMEDICAL RESEARCH; DRUG AND NARCOTIC CONTROL; HEALTH POLICY; HEROIN DEPENDENCE; HUMANS; RESEARCH DESIGN; RESEARCH SUPPORT;

EID: 2342428656     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2004.00717.x     Document Type: Review

References (69)

1. Bammer, G. (1995) Report and Recommendations of Stage 2 Feasibility Research Into the Controlled Availability of Opioids. Canberra: National Centre for Epidemiology and Population Health, Australian National University and the Australian Institute of Criminology. Available at: http://nceph.anu.edu.au/ Publications/Opioids/finalReportpdf.
2. Bammer, G. & Douglas, R. M. (1996) The ACT heroin trial proposal: an overview. Medical Journal of Australia, 164, 690-692.
3. Bammer, G., Hall, W. D., Hamilton, M. & Ali, R. (2002) Harm minimization in a prohibition context - Australia. Annals of the American Academy of Political Social Science, 582, 80-93.
4. Bell, J., Batey, R. G., Farrell, G. C. et al. (1990) Hepatitis C virus in intravenous drug users. Medical Journal of Australia, 153, 274-276.
5. Bell, J., Hall, W. D. & Byth, K. (1992) Changes in criminal activity after entering methadone maintenance. British Journal of Addiction, 87, 251-258.
6. Blewett, N. (1987) NCADA: Assumptions, Arguments and Aspirations. National Campaign Against Drug Abuse Monograph Series, vol. 1. Canberra: AGPS.
7. Caplehorn, J. R., Dalton, M. S., Haldar, F., Petrenas, A. M. & Nisbet, J. G. (1996) Methadone maintenance and addicts' risk of fatal heroin overdose. Substance Use and Misuse, 31, 177-196.
8. Darke, S. & Hall, W. D. (1997) The distribution of naloxone to heroin users. Addiction, 92, 1195-1199.
9. Darke, S., Ross, J. & Hall, W. D. (1996a) Overdose among heroin users in Sydney, Australia. 1. Prevalence and correlates of non-fatal overdose. Addiction, 91, 405-411.
10. Darke, S., Ross, J. & Hall, W. D. (1996b) Overdose among heroin users in Sydney, Australia. 2. Responses to overdose. Addiction, 91, 413-417.
11. Darke, S., Topp, L., Kaye, S. & Hall, W. D. (2002) Heroin use in New South Wales, Australia, 1996-2000: 5-year monitoring of trends in price, purity, availability and use from the Illicit Drug Reporting System (IDRS). Addiction, 97, 179-186.
12. Darke, S. & Zador, D. (1996) Fatal heroin 'overdose': a review. Addiction, 91, 1765-1772.
13. Dietze, P. & Fitzgerald, J. (2002) Interpreting changes in heroin supply in Melbourne: droughts, gluts or cycles? Drug and Alcohol Review, 21, 295-303.
14. Edwards, G. (1993) Substance misuse and the uses of science. In: Edwards, G., Strang, J. & Jaffe, J. H., eds. Drugs, Alcohol and Tobacco: Making the Science and Policy Connections, pp. 3-16. Oxford: Oxford University Press.
15. Elliott, A. & Chapman, S. (2000) 'Heroin hell their own making': construction of heroin users in the Australian press 1992-97. Drug and Alcohol Review, 19, 191-201.
16. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (1997) Estimating the Prevalence of Problem Drug Use in Europe. EMCDDA Scientific Monograph Series, vol. 1. Luxembourg: EMCDDA.
17. Farrell, M. & Hall, W. D. (1998) The Swiss heroin trials: testing alternative approaches. BMJ, 316, 639-639.
18. Farrell, M., Ward, J., Mattick, R. P., Hall, W., Stimson, G., Des Jarlais, D., Gossop, M. & Strang, J. (1994) Methadone maintenance treatment in opiate dependence - a review. BMJ, 309, 997-1001.
19. Hall, W. D. (1996a) How can we reduce heroin 'overdose' death? Medical Journal of Australia, 164, 197-198.
20. Hall, W. D. (1996b) Methadone maintenance treatment as a crime control measure. Crime and Justice Bulletin. 29, 1-12.
21. Hall, W. D. (1997) Swiss Scientific Studies of Medically Prescribed Narcotics. NDARC Technical Report no. 43. Sydney: National Drug and Alcohol Research Centre.
22. Hall, W. D. (1999) Reducing the toll of opioid overdose deaths in Australia. Drug and Alcohol Review, 18, 213-220.
23. Hall, W. D. (2000) UROD: an Antipodean therapeutic enthusiasm. Addiction, 95, 1765-1766.
24. Hall, W. D., Bell, J. & Carless, J. (1993) Crime and drug use among applicants for methadone maintenance. Drug and Alcohol Dependence, 31, 123-129.
25. Hall, W. D. & Darke, S. (1998) Trends in opiate overdose deaths in Australia 1979-95. Drug and Alcohol Dependence, 52, 71-77.
26. Hall, W. D., Degenhardt, L. & Lynskey, M. (1999a) Opioid overdose mortality in Australia, 1964-97: birth-cohort trends. Medical Journal of Australia, 171, 34-37.
27. Hall, W. D., Kimber, J. & Mattick, R. P. (2002) Breaking the deadlock over an Australian trial of injectable opioid maintenance. Medical Journal of Australia, 176, 72-73.
28. Hall, W. D., Lynskey, M. & Degenhardt, L. (1999b) Heroin Use in Australia: its impact on Public Health and Public Order. NDARC Monograph no. 42. Sydney: National Drug and Alcohol Research Centre.
29. Hall, W. D. & Mattick, R. P. (2000) Is ultra-rapid opioid detoxification a viable option in the treatment of opioid dependence? CNS Drugs, 14, 251-255.
30. Hall, W. D., Mattick, R. P., Saunders, J. B. & Wodak, A. (1997) Rapid opiate detoxification treatment. Drug and Alcohol Review, 16, 325-327.
31. Hall, W. D., Ross, J., Lynskey, M., Law, M. & Degenhardt, L. (2000) How many dependent heroin users are there in Australia? Medical Journal of Australia, 173, 528-531.
32. Hall, W. D. & Wodak, A. (1999) Is naltrexone a cure for heroin dependence? Medical Journal of Australia, 171, 9-10.
33. Hartnoll, R., Mitcheson, M., Lewis, R. & Bryer, S. (1985) Estimating the prevalence of opiod dependence. Lancet, 1, 203-205.
34. Heather, N., Tebbutt, J. & Greeley, J. (1993a) Alcohol cue exposure directed at a goal of moderate drinking. Journal of Behavior Therapy and Experimental Psychiatry, 24, 187-195.
35. Heather, N., Tebbutt, J. S., Mattick, R. P. & Zamir, R. (1993b) Development of a scale for measuring impaired control over alcohol consumption: a preliminary report. Journal of Studies on Alcohol, 54, 700-709.
36. Hulse, G., English, D., Milne, E. & Holman, C. (1999) The quantification of mortality resulting from the regular use of illicit opiates. Addiction, 94, 221-229.
37. Kehoe, L., Hall, W. D. & Mant, A. (1992) Estimates of the number of injecting drug users in a defined area. Australian Journal of Public Health, 16, 232-237.
38. Law, M. G., Lynskey, M., Ross, J. & Hall, W. D. (2001) Back-projection estimates of the number of dependent heroin users in Australia. Addiction, 96, 433-143.
39. Lawrence, G., Bammer, G. & Chapman, S. (2000) 'Sending the wrong signal': analysis of print media reportage of the ACT heroin prescription trial proposal, August 1997. Australian and New Zealand Journal of Public Health, 24, 254-264.
40. Legislative Assembly for the ACT Select Committee on HIV and Illegal Drugs and Prostitution (1991) Second Interim Report: a Feasibility Study on the Controlled Availability of Opioids. Canberra: Legislative Assembly for the Australian Capital Territory.
41. Lintzeris, N., Lenne, M. & Ritter, A. (1999) Methadone injecting in Australia: a tale of two cities. Addiction, 94, 1175-1178.
42. Lynskey, M. T. & Hall, W. (1998) Cohort trends in age of initiation to heroin use. Drug and Alcohol Review, 17, 289-297.
43. Maher, L., Dixon, D., Lynskey, M. & Hall, W. D. (1998) Running the Risks: Heroin. Health and Harm in South West Sydney. NDARC Monograph no. 38. Sydney: National Drug and Alcohol Research Centre.
44. Manderson, D. (1993) From Mr Sin to Mr Big: a History of Australian Drug Laws. Melbourne: Oxford University Press.
45. Mattick, R. P., Ali, R., White, J., O'Brien, S., Wolk, S. & Danz, C. (2003) Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction, 98, 441-452.
46. McCoy, A. W. (1980) Drug Truffic: Narcotics and Organized Crime in Australia. Sydney: Harper & Row.
47. McGregor, C., Ali, R., Christie, P. & Darke, S. (2001) Overdose among heroin users: evaluation of an intervention in South Australia. Addiction Research, 9, 481-501.
48. McGregor, C., Darke, S., Christie, P. & Ali, R. (1998) Experience of non-fatal overdose among heroin users in Adelaide: circumstances and risk perception. Addiction, 93, 701-711.
49. Nicholson, B. (1997) Divided opinions on trial plan. Canberra Times, 19 August, p. 2.
50. Parrett, C. (1997) Good news on the drugs front. Canberra Times, 17 January, p. 10.
51. Penington, D. (2002) Interview with David Penington. In: Edwards, G., ed. Addiction: Evolution of a Specialist Field, pp. 173-183. Oxford: Blackwell.
52. Room, R. (1993) Drugs, science, and policy: a view from the U.S.A. In: Edwards, G., Strang, J. & Jaffe, J. H., eds. Drugs, Alcohol and Tobacco: Making the Science and Policy Connections, pp. 26-36. Oxford: Oxford University Press.
53. Rouen, D., Dolan, K., Day, C. et al. (2001) Changes in Heroin Availability in Sydney, Australia in Early 2001. NDARC Technical Report no. 119. Sydney: National Drug and Alcohol Research Centre.
54. Rowe, J. (2002) Heroin epidemic!: drugs and moral panic in the western suburbs of Melbourne 1995-6. Just Policy, 27, 38-45.
55. Strang, J., Darke, S., Hall, W. D., Farrell, M. & Ali, R. (1996) Heroin overdose: the case for take-home naloxone - home based supplies of naloxone would save lives. BMJ, 312, 1435-1436.
56. Uchtenhagen, A., Gatzwiller, F. & Dobler-Mikola, A. (1998) Medical Prescription of Narcotics Research Programme. Final Report of the Principal Investigators. Zurich: Institut fur Sozial-und Praventivmedizin der Universitat Zurich.
57. Ward, J., Hall, W. D. & Mattick, R. P. (1998) Methadone Maintenance Treatment and Other Opioid Replacement Therapies. Amsterdam, the Netherlands: Harwood Academic.
58. Ward, J., Mattick, R. P. & Hall, W. D. (1992) Key Issues in Methadone Maintenance Treatment. Kensington, NSW: New South Wales University Press.
59. Warner-Smith, M., Darke, S., Lynskey, M. & Hall, W. D. (2001) Heroin overdose: causes and consequences. Addiction, 96, 1113-1125.
60. Watters, B. (1999) Prevention, demand reduction, and treatment: a way forward for Australia. In: Jones, B., ed. Heroin Crisis: Key Commentators Discuss the Issues and Debate Solutions to Heroin Abuse in Australia, pp. 35-45. Melbourne: Bookman Press.
61. Weatherburn, D., Jones, C., Freeman, K. & Makkai, T. (2003) Supply control and harm reduction: lessons from the Australian heroin ''drought. Addiction, 98, 83-91.
62. White, J. & Irvine, R. (1999) Mechanisms of fatal opioid overdose. Addiction, 94, 961-972.
63. Wodak, A. (1996) When medical research is beholden to politics. Medical Journal of Australia, 164, 649-650.
64. Wodak, A. (1997) We lose 500 young each year. Sydney Morning Herald, 28 January 1997, p. 14.
65. Wodak, A. (1998a) Prescribing heroin: nothing to fear but fear itself? Medical Journal of Australia, 168, 590-591.
66. Wodak, A. (1998b) The Swiss heroin trials - further studies of heroin treatment are needed. BMJ, 317, 1011.
67. Wodak, A. (2002) Heroin in the sunburnt country: droughts and flooding rains. In Touch, 19, 1-2.
68. Wodak, A., Ritter, A. J. & Watson, C. R. (2002) Separating politics and scientific research on heroin prescription. Medical Journal of Australia, 176, 449.
69. Zador, D., Sunjic, S. & Darke, S. (1996) Heroin-related deaths in New South Wales, 1992: toxicological findings and circumstances. Medical Journal of Australia, 164, 204-207.